Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $1,013 |
Sells | 13 | $48,081,486 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Feb 2025 18:57 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 13 Feb 2025 | Sale | 2,832 | 116.6895 | 330,465 | D |
14 Feb 2025 18:57 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 13 Feb 2025 | Sale | 3,012 | 116.6832 | 351,450 | D |
12 Feb 2025 18:56 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 10 Feb 2025 | Sale | 2,274 | 118.3673 | 269,167 | D |
04 Feb 2025 17:58 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 31 Jan 2025 | Sale | 2,707 | 152.9246 | 413,967 | D |
29 Jan 2025 19:03 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Director | 27 Jan 2025 | Sale | 146,105 | 149.4576 | 21,836,503 | D |
01 Oct 2024 16:09 | XNCR | Xencor Inc | GORMAN KEVIN CHARLES | Director | 27 Sep 2024 | Sale | 2,654 | 20.68 | 54,885 | D |
15 Feb 2024 17:43 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 13 Feb 2024 | Sale | 2,832 | 133.0157 | 376,700 | D |
15 Feb 2024 16:02 | XNCR | Xencor Inc | GORMAN KEVIN CHARLES | Director | 13 Feb 2024 | Purchase | 53 | 19.12 | 1,013 | D |
08 Feb 2024 19:21 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 08 Feb 2024 | Sale | 2,274 | 134.1479 | 305,052 | D |
08 Feb 2024 19:21 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 06 Feb 2024 | Sale | 3,040 | 142.1771 | 432,218 | D |
02 Feb 2024 19:21 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 31 Jan 2024 | Sale | 2,707 | 140.6888 | 380,845 | D |
10 Jan 2024 16:31 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 09 Jan 2024 | Sale | 62,023 | 134.0131 | 8,311,895 | D |
10 Jan 2024 16:31 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 08 Jan 2024 | Sale | 105,835 | 132.4375 | 14,016,523 | D |
23 Aug 2023 20:08 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 21 Aug 2023 | Sale | 9,328 | 107.3988 | 1,001,816 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)